{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:15:50Z","timestamp":1790046950720,"version":"4.0.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The proteome is a crucial reservoir of targets for cancer treatment. While some targeted therapies have been developed, there are still significant challenges in early diagnosis and treatment, highlighting the need to identify new biomarkers and therapeutic targets for breast cancer. Therefore, we conducted a comprehensive proteome-wide Mendelian randomization (MR) study to identify novel biomarkers and potential therapeutic targets for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Protein quantitative trait locus (pQTL) data were extracted from two published plasma proteome-wide association studies. Genetic variants associated with breast cancer were obtained from the Breast Cancer Association Consortium, which included 133,384 cases and 113,789 controls, and the Finnish cohort study, comprising 18,786 cases and 182,927 controls. We employed summary-based MR and colocalization methods to identify potential drug targets for breast cancer, which were subsequently validated using a two-sample MR approach. Finally, a protein-protein interaction (PPI) network was constructed to detect interactions between the identified proteins and existing cancer drug targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Gene-predicted levels of ten proteins were associated with breast cancer risk. Decreased levels of CASP8, DDX58, CPNE1, ULK3, PARK7, and BTN2A1, as well as increased levels of TNFRSF9, TNXB, DNPH1, and TLR1, were linked to an elevated risk of breast cancer. Among these, CASP8 and DDX58 were supported by tier-one evidence, while CPNE1, ULK3, PARK7, and TNFRSF9 received tier-two evidence support. The remaining proteins, TNXB, BTN2A1, DNPH1, and TLR1, were supported by tier-three evidence. CASP8, DDX58, CPNE1, ULK3, PARK7, and TNFRSF9 have already been identified as targets in drug development and potential therapeutic targets for breast cancer treatment. Additionally, ULK3 showed promise as a prognostic biomarker for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study identified several novel potential drug targets and biomarkers for breast cancer, providing new insights into its diagnosis and treatment. The integration of PPI and druggability evaluations enhances the prioritization of these therapeutic targets, paving the way for future drug development efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2024.1449668","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:43:19Z","timestamp":1726447399000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Jingshuang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.2967\/jnumed.115.157834","article-title":"Clinical diagnosis and management of breast cancer","author":"McDonald","year":"2016","journal-title":"J Nucl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature06916","article-title":"Mining the plasma proteome for cancer biomarkers","volume":"452","author":"Hanash","year":"2008","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34795","article-title":"Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study","volume":"154","author":"Peila","year":"2024","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101339","article-title":"Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer","volume":"17","author":"Thomas","year":"2022","journal-title":"Transl Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13058-018-0940-z","article-title":"Affinity\u00a0proteomic profiling of plasma for proteins associated to area-based mammographic breast density","volume":"20","author":"Bystr\u00f6m","year":"2018","journal-title":"Breast Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13058-020-01352-0","article-title":"Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort","volume":"22","author":"Monson","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34472","article-title":"Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data","volume":"152","author":"Jia","year":"2023","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32542","article-title":"Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk","volume":"146","author":"Shu","year":"2020","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01923-2","article-title":"Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis","volume":"127","author":"Shu","year":"2022","journal-title":"Br J Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1038\/s41467-023-43485-8","article-title":"Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation","volume":"14","author":"M\u00e4larstig","year":"2023","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1186\/s12967-023-04525-5","article-title":"Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers","volume":"21","author":"Ren","year":"2023","journal-title":"J Trans Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad247","article-title":"Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers","volume":"116","author":"Sun","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0609-2","article-title":"Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses","volume":"52","author":"Zhang","year":"2020","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.03.22271360","article-title":"FinnGen: Unique genetic insights from combining isolated population and national health register data","volume":"3","author":"Kurki","year":"2022","journal-title":"medRxiv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00602-7","article-title":"Systemic inflammatory markers in relation to cognitive function and measures of brain atrophy: a Mendelian randomization study","volume":"44","author":"Luo","year":"2022","journal-title":"GeroScience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12974-022-02582-z","article-title":"The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study","volume":"19","author":"Shi","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9","article-title":"Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome","volume":"15","author":"Sun","year":"2023","journal-title":"Genome Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome","volume":"34","author":"Greco M","year":"2015","journal-title":"Stat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1752-8","article-title":"Activity of caspase-8 determines plasticity between cell death pathways","volume":"575","author":"Newton","year":"2019","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.09.041","article-title":"Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency","volume":"156","author":"Lehle","year":"2019","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14932","article-title":"Casp8 acts through A20 to inhibit PD-L1 expression: The mechanism and its implication in immunotherapy","volume":"112","author":"Zou","year":"2021","journal-title":"Cancer Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10549-009-0316-2","article-title":"CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers","volume":"119","author":"Palanca Suela","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2017.10.001","article-title":"Downregulation of Caspase 8 in a group of Iranian breast cancer patients - A pilot study","volume":"29","author":"Aghababazadeh","year":"2017","journal-title":"J Egypt Natl Canc Inst"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173201","article-title":"Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis","volume":"881","author":"Hashemi","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13058-023-01631-6","article-title":"Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study","volume":"25","author":"Gunnarsdottir","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1356778","article-title":"DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis","volume":"14","author":"Cao","year":"2024","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0730","article-title":"Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers","volume":"78","author":"Elion","year":"2018","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23504","article-title":"Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms","volume":"9","author":"Fang","year":"2017","journal-title":"Oncotarget"},{"key":"B48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-018-0811-6","article-title":"CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer","volume":"37","author":"Tang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154634","article-title":"CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K\/AKT\/HIF-1\u03b1 signaling","volume":"248","author":"Cao","year":"2023","journal-title":"Pathology Res practice"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23177","article-title":"CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer","volume":"59","author":"Shao","year":"2020","journal-title":"Mol Carcinog"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.02.010","article-title":"DJ-1, a novel regulator of the tumor suppressor PTEN","volume":"7","author":"Kim","year":"2005","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1340917","article-title":"Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers","volume":"10","author":"Wang","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2559.2012.04202.x","article-title":"Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast","volume":"61","author":"Tsuchiya","year":"2012","journal-title":"Histopathology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/5041223","article-title":"DJ-1: A potential biomarker related to prognosis, chemoresistance, and expression of microenvironmental chemokine in HR-positive breast cancer","volume":"2023","author":"Xie","year":"2023","journal-title":"J Immunol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4738","article-title":"Twists and turns to translating 4-1BB cancer immunotherapy","volume":"11","author":"Sanmamed","year":"2019","journal-title":"Sci Trans Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2023.0022","article-title":"4-1BB targeting immunotherapy: mechanism, antibodies, and chimeric antigen receptor T","volume":"38","author":"Shen","year":"2023","journal-title":"Cancer biotherapy radiopharmaceuticals"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0364","article-title":"4-1BB-enhanced expansion of CD8+ TIL from triple-negative breast cancer unveils mutation-specific CD8+ T cells","volume":"5","author":"Harao","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1101\/gad.519709","article-title":"Autophagy mediates the mitotic senescence transition","volume":"23","author":"Young","year":"2009","journal-title":"Genes Dev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41467-023-36410-6","article-title":"he\u00a0ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome","volume":"14","author":"Goruppi","year":"2023","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.602174","article-title":"A prognostic model for colon cancer patients based on eight signature autophagy genes","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v13i14","article-title":"Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Aging"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1449668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:43:23Z","timestamp":1726447403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1449668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":61,"alternative-id":["10.3389\/fendo.2024.1449668"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1449668","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"article-number":"1449668"}}